Figure 5.
Positive and negative predictive values for patients with AS with AAU for centiles of genetic risk scores. The assumed prevalence of patients with AS with AAU of 0.3% among the population (a), and assumed prevalence of 20% in outpatient clinics (b). Error Bars denote 2 standard deviations based on 10-fold cross validation.